No Data
No Data
No Data
No Data
No Data
Express News | Lipella Pharmaceuticals Expands Its Advisory Board to Include Oncology Expertise
Moomoo 24/7Apr 17 08:00 ET
Express News | Maxim Group Initiates Coverage On Lipella Pharmaceuticals With Buy Rating, Announces Price Target of $2
Moomoo 24/7Apr 9 11:36 ET
Lipella Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/09/2024 185.92% Maxim Group → $2 Initiates Coverage On → Buy
BenzingaApr 9 11:35 ET
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) ("Lipella," "our", "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant
GlobeNewswireApr 5 08:00 ET
Express News | Lipella Pharmaceuticals Announces FDA Type C Meeting For LP-10 For Hemorrhagic Cystitis; Co. Expects To Meet With FDA May 21
Moomoo 24/7Apr 3 08:02 ET
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with
GlobeNewswireApr 3 08:00 ET
Jaguar8 : Several huge insider loading . HMMM
TrytosaveabitOP Jaguar8: Yes hmm is correct! Hehehe
Jaguar8 TrytosaveabitOP: I love the hmm is correct
TrytosaveabitOP Jaguar8: Hehehe!
Jaguar8 TrytosaveabitOP: Are you holding anything overnight?
dSuu : good news fails
Mcsnacks H Tupack : I'm in at .78
FattyChickOP Mcsnacks H Tupack: Looking at 0.558 as entry.
No Data
No Data
TrytosaveabitOP : Co. Expects To Meet With FDA May 21